Sedation for flexible bronchoscopy in children

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00008589

Enrollment

Registered

2015-06-02

Start date

2015-03-02

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedation for bronchoscopy

Interventions

Group 1: start with Propofol=Propofol1% for sleep induction 10mg/kgKG/h, if necessary additionally single doses of 0,5mg/kgKG after 10min Remifentanil=Ultiva 4mg/kg/h Group 2: start with Propofol=Pr

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: Bronchoscopy necessary for medical reason

Exclusion criteria

Exclusion criteria: dyspnea intolerance for applied medication noninvasive/invasive ventilation

Design outcomes

Primary

Measure	Time frame
Frequency of episodes of coughing during sedation for bronchoscopy. One episode of coughing is defined as any coughing without inspiration within.	—

Secondary

Measure	Time frame
frequency of complications during sedation for bronchoscopy	—

Countries

Germany

Contacts

Public ContactEva Tschiedel

Universitätsklinik Essen Klinik für Kinderheilkunde 1

eva.tschiedel@uk-essen.de0201/7232251

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 5, 2026